A special issue of the Marine Technology Society Journal, titled “Utilizing Offshore Resources for Renewable Energy Development,” focuses on research and development efforts including those at Pacific Northwest National Laboratory (PNNL).
PNNL researchers say that offshore wind energy can add value to the electric grid, beyond just the power it can produce, if locations and strategies are optimized.
PNNL deployed two research buoys in waters off the West Coast for the first time in deep water, supporting a DOE and Bureau of Ocean Energy Management effort to gather measurements that support offshore wind locations and technologies.
Twelve researchers from PNNL presented at the 2020 Metabolomics Association of North America virtual conference in mid-September. Their presentations included a plenary talk, keynote talks, oral presentations, posters, and a lightning talk.
Pacific Northwest National Laboratory (PNNL) is part of a continuing National Science Foundation (NSF) team investigating the environmental impact of nanoparticles at the molecular level.
PNNL ocean engineer Alicia Gorton was invited to serve on the advisory board of the Department of Civil, Environmental, and Ocean Engineering at the Stevens Institute of Technology.
Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.
Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.
After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.
Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.
